Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection

Clinical Immunology and Immunopathology

Volumn 86, Issue 3, 1998, Pages 246-251

  Tsai, Jung Fa ^b   Margolis, Harold S ^a   Jeng, Jen Eing ^c   Ho, Mei Shang ^c   Chang, Wen Yu ^c   Hsieh, Min Yuh ^c   Lin, Zu Yau ^c   Tsai, Juei Hsiung ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NONE

Author keywords

Chronic hepatitis B virus infection; Circulating immune complexes; Conglutinin and C1q immune complex assays; HBsAg specific immune complex

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; CHINESE; CHRONIC HEPATITIS; FEMALE; HEPATITIS B; HUMAN; IMMUNOPATHOGENESIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 0032030907     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4477     Document Type: Article

References (34)

1. Di Bisceglie A. M., Hoofnagle J. H. Chronic viral hepatitis. Hepatology: A Textbook of Liver Disease. 1996;Saunders, Philadelphia. p. 1299-1329.
2. Paroli M., Franco A., De Petrillo G., Benvenuto R., Barnaba V. Cellular immune reactions to hepatitis B envelope antigens. meyer zum Buschenfelde K. H., Hoofnagle J. H., Manns M. Immunology and Liver. 1993;48-51 Kluwer, Dordrecht.
3. Chisari F. V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:1995;29-60.
4. Moriyama T., Guilhot S., Klopchin K., Moss B., Pinkert C. A., Palmiter R. D., Brinster R. L., Kanagawa O., Chisari S. V. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 248:1990;361-364.
5. Celie E., Chang T. W. HBsAg-serum protein complexes stimulate immune T lymphocytes more efficiently than do pure HBsAg. Hepatology. 4:1984;1116-1123.
6. Casali P., Oldstone M. B. A. Immune complexes in viral infection. Curr. Top. Microbiol. Immunol. 104:1983;7-48.
7. Tsai J. F., Tsai J. H., Chang W. Y. Relationship of serum α-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Gastroenterol. Jpn. 25:1990;388-393.
8. Tsai J. F., Tsai J. H., Chang W. Y., Tong T. C. Elevation of circulating immune complexes and its relationship to α-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma. Cancer Invest. 9:1991;137-143.
9. Tsai J. F., Margolis H. S., Jeng J. E., Ho M. S., Chang W. Y., Lin Z. Y., Tsai J. H. Circulating immune complexes in chronic hepatitis related to hepatitis C and B viruses infection. Clin. Immunol. Immunopathol. 75:1995;39-44.
10. Tsai J. F., Jeng J. E., Chang W. Y., Ho M. S., Lin Z. Y., Tsai J. H. Increased IgM-containing circulating immune complexes in patients co-infected with hepatitis C and hepatitis B. Medicine. 74:1995;136-143.
11. Tsai J. F., Jeng J. E., Chang W. Y., Ho M. S., Lin Z. Y., Tsai J. H. Circulating immune complexes in chronic hepatitis C. J. Med. Virol. 46:1995;12-17.
12. Tsai J. F., Jeng J. E., Chang W. Y., Ho M. S., Lin Z. Y., Tsai J. H. Clinical evaluation of serum α-fetoprotein and circulating immune complexes as tumor markers of hepatocellular carcinoma. Br. J. Cancer. 72:1995;442-446.
13. Margolis H. S., Nanian O. V., Fields H. A., Bradley D. W. Characteristics of chemically aggregated IgM in an immunoglobulin class-specific immune complex assay. J. Immunol. Methods. 102:1987;23-31.
14. Abrass C. K., Border W. A., Hepner G. Nonspecificity of circulating immune complexes in patients with acute and chronic liver diseases. Clin. Exp. Immunol. 40:1980;292-298.
15. Brown S. E., Steward M. W., Viola L., Howard C. R., Murry-Lyon I. M. Chronic liver disease: The detection and characterization of circulating immune complexes. Immunology. 49:1983;673-683.
16. Jones V. E., Orlans E. Isolation of immune complexes and characteristics of their constituent antigens and antibodies in some human diseases: A review. J. Immunol. Methods. 44:1981;249-270.
17. Tsai J. F., Margolis H. S., Jeng J. E., Ho M. S., Chang W. Y., Hsieh M. Y., Lin Z. Y., Tsai J. H. Increased IgM class circulating immune complexes in acute hepatitis A virus infection. Clin. Immunol. Immunopathol. 78:1996;291-295.
18. Tsai J. F., Margolis H. S., Jeng J. E., Ho M. S., Chang W. Y., Hsieh M. Y., Lin Z. Y., Tsai J. H. Hepatitis B surface antigen- and immunoglobulin-specific circulating immune complexes in acute hepatitis B virus infection. Clin. Immunol. Immunopathol. 80:1996;278-282.
19. Stransky J., Vodak M., Zichova M. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B. Acta Virol. 37:1993;170-174.
20. Tsai J. F., Margolis H. S., Fields H. A., Nainan O. V., Chang W. Y., Tsai J. H. Immunoglobulin and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis with hepatitis delta virus infection. J. Med. Virol. 30:1990;25-29.
21. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., Lortholary O., Thibult N., Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: A prospective study in 342 patients. Medicine. 75:1996;17-28.
22. Roitt I. M., Brostoff J., Male D. K. Immunology. 1985;Blackwell, Oxford. p. 10.2-10.3.
23. Troisi C. L., Hollinger F. B. Detection of an IgM anti-idiotype directed against anti-HBs in hepatitis B patients. Hepatology. 5:1985;758-762.
24. Lancet. 2:1977;914-919.
25. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Wang L. Y., Hsieh M. Y., Chen S. C., Chuang W. L., Lin Z. Y., Tsai J. H. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J. Med. Virol. 41:1993;296-300.
26. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver. 14:1994;98-102.
27. Veerhuis R., Krol M. C., van Es L. A., Daha M. R. Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo. Clin. Immunol. Immunopathol. 41:1986;379-391.
28. Stanworth D. R., Turner M. W. Immunochemical analysis of human and rabbit immunoglobulins and their subunits. Weir D. M. Handbook of Experimental Immunology. Immunochemistry. 1:1985;12.1-12.46 Blackwell, Oxford.
29. Markenson J. M., Daniels C. A., Notkims A. L., Hoofnagle J. H., Getety J., Barker L. F. The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes. Clin. Exp. Immunol. 19:1975;209-217.
30. Sansonno D. E., Detomaso P., Papanice M. A., Primavera M. V., Manghisi O. G. Autoantibody to albumin of type G and M in acute and chronic viral hepatitis. Hepatogastroenterology. 33:1986;14-16.
31. Charlesworth J. A., Quin J. W., MacDonald G. J., Lennane R. J., Boughton C. R. Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: Serial studies in uncomplicated cases. Clin. Exp. Immunol. 34:1978;241-247.
32. Trepo C., Zoulim F., Alonso C., Petit M. A., Pichoud C., Vitvitski L. Diagnostic markers of viral hepatitis B and C. Gut. 1993;s20-s25.
33. Devy M. E., Taylor J., Steward M. W. Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays. J. Immunol. Methods. 34:1980;191-203.
34. Tsai J. F., Jeng J. E., Ho M. S., Wang C. S., Chang W. Y., Hsieh M. Y., Lin Z. Y., Tsai J. H. Serum alanine aminotransferase level in relation to hepatitis B and C viruses infection among blood donors. Liver. 17:1997;24-29.